|
FazaClo. The CATIE-2 authors
concluded: "Given the superior effectiveness of clozapine
relative to all other antipsychotics, efforts to develop models of
service delivery that would encourage its greater use are warranted."
Azur Pharma is committed to providing support services consistent with
the CATIE-2 recommendations for expanded use of clozapine through such
improved service delivery concepts as the development and expansion of
clozapine clinics. With FazaClo brand of clozapine, therapeutic
outcomes may be enhanced because Azur Pharma provides unique services
to help doctors manage a greater number of patients safely.
Patient Safety Support Services Unique
to
FazaClo. When doctors prescribe FazaClo - the more convenient
orally disintegrating tablet form of clozapine - Azur Pharma provides
the possibility of unique safety support services. These include a 24/7
medical hotline and a nationwide team of FazaClo Systems Consultants -
health professionals specially trained to organize, expedite and
maintain the requisite blood test results designed to enhance patient
safety3.
How FazaClo May Improve the CATIE
Outcomes.
Taking the CATIE data as the baseline, one can envision even better
results with FazaClo orally disintegrating tablets, because Azur Pharma
gives doctors and clinics help they may need to optimize treatment
safety. Clinical study data show that 8 out of 10 patients crossed-over
from an older form of clozapine say they like taking FazaClo orally
disintegrating clozapine formulation4.
And, when patients like taking their medication, they are much more
likely to continue treatment.
For more information follow these links:
|
